Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             99 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Author index 2004
 14 S1 p. S77-S79
3 p.
 artikel
2 Keyword index 2004
 14 S1 p. S81-S82
2 p.
 artikel
3 P.3.12 Abnormalities of corpus callosum in schizophrenia: a diffusion-weighted MRI study Brambilla, P.
 2004
 14 S1 p. S54-S55
2 p.
 artikel
4 P.2.16 ACTH(4–10) analogue SEMAX attenuates opioid-induced analgesia Ivanova, D.M.
 2004
 14 S1 p. S32-S33
2 p.
 artikel
5 P.2.08 Acute hypercapnic gas challenge increases c-Fos in topographically organised histaminergic neurones Johnson, P.L.
 2004
 14 S1 p. S27-
1 p.
 artikel
6 P.3.21 A microarray analysis of gene expression pre- and post-lithium treatment in acute mania: molecular signal transduction pathways Kirkby, L.
 2004
 14 S1 p. S61-S62
2 p.
 artikel
7 P.3.19 A naturalistic study on quetiapine vs. other mood stabilizers in the treatment of bipolar disorder I and II Tacchini, G.
 2004
 14 S1 p. S60-
1 p.
 artikel
8 P.3.03 An fMRI study of executive function in first episode schizophrenia Matthiasson, P.
 2004
 14 S1 p. S48-S49
2 p.
 artikel
9 P.2.17 Antenatal hypoxia influence on the development of CNS Graf, A.V.
 2004
 14 S1 p. S33-S34
2 p.
 artikel
10 P.2.28 Antidepressant-like effects of tiagabine on locomotor/exploratory behaviour and leukocyte phagocytosis in rats Pistovcakova, J.
 2004
 14 S1 p. S41-S42
2 p.
 artikel
11 P.2.01 Anxiogenic drugs act selectively on topographically distinct midbrain, pontine, and medullary serotonergic neurones Abrams, J.K.
 2004
 14 S1 p. S21-
1 p.
 artikel
12 P.3.20 Arrythmic markers affected by clozapine treatment in patients with schizophrenia: heart rate variability, late potentials and QT dispersion Tümüklü, M.N.
 2004
 14 S1 p. S60-S61
2 p.
 artikel
13 P.1.16 Association between serotonin-related genetic polymorphisms and cholecystokinin tetrapeptide induced panic attacks in healthy volunteers Maron, E.
 2004
 14 S1 p. S14-S15
2 p.
 artikel
14 P.1.06 Brain-derived neurotrophic factor (BDNF) gene in unipolar affective disorder: a Belgian patient-control association study Oswald, P.
 2004
 14 S1 p. S7-
1 p.
 artikel
15 P.3.04 Brain networks in sleep as revealed by combined EEG and fMRI Wehrle, R.
 2004
 14 S1 p. S49-
1 p.
 artikel
16 P.4.15 Changes in subunit composition of N-methyl-D-aspartate receptor in animal model of schizophrenia: effect of subunit selective antagonist Skuba, I.
 2004
 14 S1 p. S73-S74
2 p.
 artikel
17 P.1.02 Chronic cocaine treatment induces ΔFosB expression and accumulation in CRH-positive neurons of the rat paraventricular nucleus of hypothalamus Chocyk, A.
 2004
 14 S1 p. S3-S4
2 p.
 artikel
18 P.3.07 Chronic daily headache with and without overuse: one or two different psychobiological entities? A study using tridimensional personality Questionnaire Di Stani, F.
 2004
 14 S1 p. S51-
1 p.
 artikel
19 P.3.11 Cognitive function and psychomotor performance in schizophrenic patients Borgwardt, S.
 2004
 14 S1 p. S53-S54
2 p.
 artikel
20 P.3.10 Combination treatment for panic disorder: a prospective study Bergesio, C.
 2004
 14 S1 p. S53-
1 p.
 artikel
21 P.2.18 Comparison of NK1−/− and NK1+/+ mice in a light/dark shuttle-box and effects of the antidepressant desipramine Herpfer, I.
 2004
 14 S1 p. S34-
1 p.
 artikel
22 P.1.03 Constitutive activity of the recombinant and native histamine H3 receptor: effects of inverse agonists and protean agonists Gbahou, F.
 2004
 14 S1 p. S4-S5
2 p.
 artikel
23 P.2.13 Co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex: implication for the neurobiology of psychiatric disorders Zuddas, A.
 2004
 14 S1 p. S30-S31
2 p.
 artikel
24 P.3.14 Depression and epilepsy: searching for the most potent mood stabilisers among antiepileptics Djokic, G.
 2004
 14 S1 p. S56-S57
2 p.
 artikel
25 P.1.10 Diverse psychotomimetics act through a common signaling pathway Svenningsson, P.
 2004
 14 S1 p. S9-S10
2 p.
 artikel
26 P.3.09 Drug-induced hypomania in anxiety disorders Albert, U.
 2004
 14 S1 p. S52-S53
2 p.
 artikel
27 P.1.19 Effect of chronic lithium and valproate treatment on gene expression of inositol-producing enzymes Shamir, A.
 2004
 14 S1 p. S17-
1 p.
 artikel
28 P.1.09 Effect of desipramine on the transcriptional activity of the dopamine D2 receptor gene promoter in the Neuro-2a cell line Solich, J.
 2004
 14 S1 p. S9-
1 p.
 artikel
29 P.3.08 Effect of different neurochemicals on peripheral BDNF production Mantua, V.
 2004
 14 S1 p. S51-S52
2 p.
 artikel
30 P.2.26 Effect of interferon-α treatment on behaviour and immunity Myint, A.-M.
 2004
 14 S1 p. S40-
1 p.
 artikel
31 P.2.05 Effects of early life experience on behaviour during social defeat and subsequent changes in serotonergic and non-serotonergic neurones within the dorsal raphe nucleus (DRN) Gardner, K.L.
 2004
 14 S1 p. S24-S25
2 p.
 artikel
32 P.2.03 Effects of fluvoxamine on HPA-axis reactivity in transgenic mice overexpressing corticotropin-releasing factor Dirks, A.
 2004
 14 S1 p. S22-S23
2 p.
 artikel
33 P.2.02 Effects of naltrexone, naltrindole and U50,488H on the initiation of intravenous cocaine self-administration in drug naïve mice Blokhina, E.A.
 2004
 14 S1 p. S21-S22
2 p.
 artikel
34 P.2.19 Efference copy. The motoric command for head bobbing in pigeons Nathaniel, I.T.
 2004
 14 S1 p. S34-S35
2 p.
 artikel
35 P.1.08 Endothelial nitric oxide synthase (NOS-III) knockout differentially affects the regulation of adult neurogenesis in mice Reif, A.
 2004
 14 S1 p. S8-
1 p.
 artikel
36 P.2.30 Evidence for reduced anxiety in mice lacking CCK2 receptors Raud, S.
 2004
 14 S1 p. S43-
1 p.
 artikel
37 P.1.20 Fluoxetine pretreatment affects pentylenetetrazol-induced neuronal activation in the rat hippocampus Zienowicz, M.
 2004
 14 S1 p. S18-
1 p.
 artikel
38 P.1.12 Functional role of galanin and its receptors in hippocampal synaptic plasticity: Electrophysiological studies on transgenic mice Xu, Z.-Q.D.
 2004
 14 S1 p. S11-S12
2 p.
 artikel
39 P.2.25 GABAB receptors play a key role in the modulation of anxiety and antidepressant-related behaviour: genetic and pharmacological evidence Mombereau, C.
 2004
 14 S1 p. S39-S40
2 p.
 artikel
40 P.1.15 GABA receptor modulation of 5-HT neuronal firing in the dorsal raphe nucleus and its sensitivity to moderate variations in corticosterone levels Judge, S.
 2004
 14 S1 p. S13-S14
2 p.
 artikel
41 P.1.07 Gene expression profiling to identify new targets associated with schizophrenia and its treatment Parsons, M.
 2004
 14 S1 p. S7-S8
2 p.
 artikel
42 P.4.16 GSK-3β in cerebrospinal fluid of schizophrenic patients Kozlovsky, N.
 2004
 14 S1 p. S74-S75
2 p.
 artikel
43 P.2.23 Habenula lesion causes attention deficits in rats: implications for cognition and schizophrenia Lecourtier, L.
 2004
 14 S1 p. S38-
1 p.
 artikel
44 P.1.05 HTR2C (cys23ser) polymorphism influences early onset in bipolar patients in a large European multicenter genetic association study Massat, I.
 2004
 14 S1 p. S6-
1 p.
 artikel
45 P.2.04 Hypothalamic histochemistry in different genetic models of anorexia Fetissov, S.O.
 2004
 14 S1 p. S23-S24
2 p.
 artikel
46 P.2.11 Identification of GABAA receptor subtypes involved in tolerance against the sedative action of diazepam van Rijnsoever, C.
 2004
 14 S1 p. S29-
1 p.
 artikel
47 P.3.17 Immunotropic influence of acute or chronic administration of Nootrop on the function of the GABA-ergic system in patients with Major Depression Minenko, S.
 2004
 14 S1 p. S58-S59
2 p.
 artikel
48 P.3.01 Increased brain volumes in medication naive high-functioning subjects with autism Palmen, S.
 2004
 14 S1 p. S47-
1 p.
 artikel
49 P.1.18 Inositol monophosphatase, 3′-phosphoadenosine 5′-phosphate phosophatase and glycogen synthase kinase-3 are less active in human brain than rat brain Shaltiel, G.
 2004
 14 S1 p. S16-S17
2 p.
 artikel
50 P.2.12 Interaction between metabotropic glutamate 5 receptors and NPY in the amygdala as a novel mechanism of anxiolysis Wieronska, J.
 2004
 14 S1 p. S29-S30
2 p.
 artikel
51 P.1.04 Interactions of GIPC with dopamine D2, D3 but not D4 receptors define a novel mode of regulation of G protein-coupled receptors Jeanneteau, F.
 2004
 14 S1 p. S5-
1 p.
 artikel
52 P.3.05 In vivo 123Iodobenzamide SPECT quantification of striatal dopamine D2 receptor occupancy of risperidone depot in patients with psychosis Wiesegger, G.
 2004
 14 S1 p. S49-S50
2 p.
 artikel
53 P.4.13 Is there association between soft signs and clinical picture in schizophrenia? Prikryl, R.
 2004
 14 S1 p. S72-S73
2 p.
 artikel
54 P.2.06 Leptin treatment in activity-based anorexia Hillebrand, J.
 2004
 14 S1 p. S25-S26
2 p.
 artikel
55 P.2.29 Lesion of serotonin system in the early period after birth — behavioral consequences in adult animals Rok-Bujko, P.
 2004
 14 S1 p. S42-S43
2 p.
 artikel
56 P.2.09 Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress Müller, M.B.
 2004
 14 S1 p. S27-S28
2 p.
 artikel
57 P.2.10 Monoaminergic neurotransmission in sleep-wake promoting brain areas: Effects of sleep deprivation and the GABAA receptor antagonist bicuculline Peñalva, R.G.
 2004
 14 S1 p. S28-S29
2 p.
 artikel
58 P.1.14 Neurobiological and behavioral effects of chronic mild stress in glucocorticoid receptor-impaired transgenic mice Froger, N.
 2004
 14 S1 p. S13-
1 p.
 artikel
59 P.4.18 Neuroimaging changes in an animal model of schizophrenia Risterucci, C.
 2004
 14 S1 p. S76-
1 p.
 artikel
60 P.3.13 Neurotrophic and antipsychotic therapy of childhood autism Krasnoperova, M.G.
 2004
 14 S1 p. S55-S56
2 p.
 artikel
61 P.2.20 Nicotine antagonizes caffeine-induced but not pentylenetetrazole-induced anxiogenic effect in mice Kayir, H.
 2004
 14 S1 p. S35-S36
2 p.
 artikel
62 P.2.15 Olanzapine, but not haloperiool, improves cognitive performance in an animal model of amnesia induced by β-amyloid peptides Consoli, D.
 2004
 14 S1 p. S32-
1 p.
 artikel
63 P.3.02 Personality traits as predictors of treatment response in patient with affective disorder Linotte, S.
 2004
 14 S1 p. S47-S48
2 p.
 artikel
64 P.4.17 Pharmacological effects of phencyclidine: dependence on cGMP signaling Pålsson, E.
 2004
 14 S1 p. S75-S76
2 p.
 artikel
65 P.2.21 Phencyclidine increases prepulse inhibition of acoustic startle in neuronal nitric oxide synthase deficient mice Klamer, D.
 2004
 14 S1 p. S36-S37
2 p.
 artikel
66 P.3.22 Prefrontal cortex dysfunction in an animal model for neurodevelopmental psychopathological disorders Diergaarde, L.
 2004
 14 S1 p. S62-
1 p.
 artikel
67 P.1.13 Preliminary characterization of the platelet dopamine transporter in human blood platelets Baroni, S.
 2004
 14 S1 p. S12-
1 p.
 artikel
68 P.3.06 Proline peptidase activities decreased in bipolar disorder not schizophrenia Breen, G.
 2004
 14 S1 p. S50-S51
2 p.
 artikel
69 P.3.18 Rivastigmine therapy for memory deficits in schizophrenia patients receiving electroconvulsive treatment Ophir, D.
 2004
 14 S1 p. S59-S60
2 p.
 artikel
70 P.4.14 Schizophrenia and bipolar affective disorder possibly linked to chromosome 3q29 Schosser, A.
 2004
 14 S1 p. S73-
1 p.
 artikel
71 P.1.11 Selective effects of antidepressants on CREB phosphorylation and related kinase cascade Tiraboschi, E.
 2004
 14 S1 p. S10-S11
2 p.
 artikel
72 P.1.17 Separate and combined effects of fluoxetine and a 5-HT1A receptor agonist or antagonist on 5-HT1A and 5-HT1B autoreceptor activity in the rat brain Shalom, G.
 2004
 14 S1 p. S15-S16
2 p.
 artikel
73 P.4.11 Specific alterations of brain membranes in schizophrenia Eckert, G.P.
 2004
 14 S1 p. S71-
1 p.
 artikel
74 P.3.15 The effect of typical and atypical neuroleptics on working memory in schizophrenic patients Libera, U.
 2004
 14 S1 p. S57-
1 p.
 artikel
75 P.2.24 The effects of acute hypoxia on the regional cerebral blood flow: peptidergic correction Maslova, M.V.
 2004
 14 S1 p. S38-S39
2 p.
 artikel
76 P.2.14 The effects of ibuprofen and curcumin on spatial working memory following an injection of aggregated Beta-amyloid(1–42) into the CA3 area of the rat hippocampus Ardis, T.C.
 2004
 14 S1 p. S31-
1 p.
 artikel
77 P.2.22 The influence of selective agonists at cannabinoid CB1 receptor and CB2 receptor on sensitization to methamphetamine behavioural effects in mice Landa, L.
 2004
 14 S1 p. S37-
1 p.
 artikel
78 P.3.16 The intensity dependence of the auditory evoked N1-amplitude as a predictor of response to citalopram-treatment in major depression Linka, T.
 2004
 14 S1 p. S58-
1 p.
 artikel
79 P.2.07 The nucleus accumbens and cocaine self-administration: dissociating the role of core and shell sub-regions Ito, R.
 2004
 14 S1 p. S26-
1 p.
 artikel
80 P.4.12 The relationship between EEG coherence and regional brain metabolism in patients with schizophrenia Espa-Cervena, K.
 2004
 14 S1 p. S71-S72
2 p.
 artikel
81 P.1.01 The role of neurogenesis in addiction and depression Brené, S.
 2004
 14 S1 p. S3-
1 p.
 artikel
82 P.2.27 Topographical evaluation of spontaneous and agonist-induced behaviour in mutants with congenic dopamine D4 versus D5 receptor knockout O'Sullivan, G.J.
 2004
 14 S1 p. S41-
1 p.
 artikel
83 S.4.06 An association study of dopaminergic genes in a sample of 283 Dutch schizophrenic patients Hoogendoorn, M.L.C.
 2004
 14 S1 p. S67-
1 p.
 artikel
84 S.4.07 Applications of pharmacogenetics and pharmacogenomics in the improvement of psychiatric treatment Mancama, D.
 2004
 14 S1 p. S68-
1 p.
 artikel
85 S.4.04 Brain volume changes in patients with schizophrenia: a 5-year longitudinal MRI study across the age range van Haren, N.
 2004
 14 S1 p. S65-S66
2 p.
 artikel
86 S.4.2 Developmental and non-developmental targets Murray, R.M.
 2004
 14 S1 p. S63-
1 p.
 artikel
87 S.4.02 Dopamine 3 (D3) receptors genetic variants: influence in schizophrenia and antipsychotic response Clark, D.
 2004
 14 S1 p. S64-S65
2 p.
 artikel
88 S.4.09 Endogenous serotonin excites GABAergic neurons of the rat prefrontal cortex through the activation of 5-HT3 receptors Santana, N.
 2004
 14 S1 p. S69-S70
2 p.
 artikel
89 S.1.1 Genetic evidence that the amounts of pathogenic proteins matter in the pathogeneses of Alzheimer's and Parkinson's diseases Hardy, J.
 2004
 14 S1 p. S1-
1 p.
 artikel
90 S.3.1 Imaging in clinical research — Perspectives on time and functional analysis Ingvar, M.
 2004
 14 S1 p. S45-
1 p.
 artikel
91 S.4.03 Long-term administration of olanzapine or clozapine, but not haloperidol, antagonizes the stress-induced increase in dopamine output in the rat prefrontal cortex Dazzi, L.
 2004
 14 S1 p. S65-
1 p.
 artikel
92 S.4.10 Modulation of mesocortical dopaminergic system by prefrontal 5-HT2 receptors. Effects of antipsychotic drugs Scorza, M.C.
 2004
 14 S1 p. S70-
1 p.
 artikel
93 S.2.1 Neuromodulators at the behavioral level Ögren, S.O.
 2004
 14 S1 p. S19-S20
2 p.
 artikel
94 S.2.2 Neuropsychopharmacology: bridging animal and human studies Robbins, T.W.
 2004
 14 S1 p. S20-S21
2 p.
 artikel
95 S.1.2 Pharmacogenetics in the treatment of schizophrenia Reynolds, G.P.
 2004
 14 S1 p. S1-S2
2 p.
 artikel
96 S.3.2 Progressive brain changes in schizophrenia as an endophenotype Kahn, R.S.
 2004
 14 S1 p. S45-S47
3 p.
 artikel
97 S.4.05 Reduced N-acetyl aspartate levels in the temporal cortex of rats reared in isolation Harte, M.
 2004
 14 S1 p. S66-S67
2 p.
 artikel
98 S.4.01 Stimulation of α 1-adrenergic and AMPA receptors in rat medial prefrontal cortex increases local in vivo serotonin release: reversal by antipsychotic drugs Amargós-Bosch, M.
 2004
 14 S1 p. S63-S64
2 p.
 artikel
99 S.4.08 Temporal and anatomical characterization of stress-related changes on BDNF expression in the rat central nervous system Molteni, R.
 2004
 14 S1 p. S68-S69
2 p.
 artikel
                             99 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland